2. Academic Validation
  3. Pentacyclic Cytochalasins and Their Derivatives from the Endophytic Fungus Phomopsis sp. xz-18

Pentacyclic Cytochalasins and Their Derivatives from the Endophytic Fungus Phomopsis sp. xz-18

  • Molecules. 2021 Oct 28;26(21):6505. doi: 10.3390/molecules26216505.
Guichon Huang 1,  Weiwen Lin 1,  Hanpeng Li 1,  Qian Tang 1,  Zhiyu Hu 1,  Huiying Huang 1,  Xianming Deng 1 2,  Qingyan Xu 1 2
Affiliations

Affiliations

  • 1 State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361102, China.
  • 2 State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products, Xiamen University, Xiamen 361102, China.
PMID: 34770914 DOI: 10.3390/molecules26216505
Abstract

Eight new cytochalasins 1-8 and ten known analogs 9-18 were isolated from the endophytic fungus Phomopsis sp. xz-18. The planar structures of the cytochalasins were determined by HR-ESI-MS and NMR analysis. Compounds 1, 2, 9 and 10 were 5/6/6/7/5-fused pentacyclic cytochalasins; compounds 3 and 4 had conjugated diene structures in the macrocycle; and compound 6 had a β,γ-unsaturated ketone. The absolute configuration of 6 was confirmed for the first time by the octant rule. The acid-free purification process proved that the pentacyclic system was a natural biosynthetic product and not an acid-mediated intramolecular cyclized artifact. The new compounds did not exhibit activities against human Cancer cell lines in cytotoxicity bioassays or antipathogenic Fungal activity, but compounds 1, 3 and 4 showed moderate Antibacterial activity in disk diffusion assays.

Keywords

antibacterial activity; cytochalasins; octant rule; pentacyclic system.

Figures
Products